Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.09T | 1.56T | 1.15T | 1.14T | 1.24T | 1.07T |
Gross Profit | 77.56B | -1.23T | -181.27B | 748.88B | 853.11B | 238.44B |
EBITDA | 882.49B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 211.47B | 165.86B | 92.79B | 143.00B | 153.12B | 217.00B |
Balance Sheet | ||||||
Total Assets | 49.24T | 55.15T | 47.77T | 43.41T | 42.52T | 44.00T |
Cash, Cash Equivalents and Short-Term Investments | 4.11T | 4.24T | 4.52T | 3.64T | 4.16T | 3.87T |
Total Debt | 11.40T | 14.09T | 11.74T | 10.90T | 9.94T | 10.17T |
Total Liabilities | 46.04T | 51.70T | 44.55T | 40.44T | 39.76T | 41.27T |
Stockholders Equity | 3.14T | 3.35T | 3.15T | 2.91T | 2.69T | 2.65T |
Cash Flow | ||||||
Free Cash Flow | 466.93B | -13.14B | -1.15T | -1.48T | 545.89B | -222.69B |
Operating Cash Flow | 591.09B | 132.64B | -974.75B | -1.37T | 665.77B | -15.94B |
Investing Cash Flow | -1.19T | -887.94B | 38.95B | -45.30B | -139.03B | 216.34B |
Financing Cash Flow | 793.38B | 1.01T | 1.29T | 1.07T | -269.93B | 332.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $231.25B | 16.91 | 13.88% | 2.57% | 6.53% | 55.54% | |
80 Outperform | $30.72B | 26.59 | 40.36% | 0.31% | 26.32% | 8.63% | |
77 Outperform | $32.28B | 15.41 | 18.84% | 1.25% | 11.78% | 25.68% | |
69 Neutral | $222.05B | 16.79 | 12.26% | 1.66% | 7.70% | 68.64% | |
67 Neutral | $11.74B | 21.56 | 5.86% | 2.81% | 0.84% | 46.98% | |
67 Neutral | ¥722.93B | 10.85 | 7.44% | 3.36% | 7.82% | 15.26% | |
61 Neutral | $19.03B | 8.93 | 9.88% | 5.84% | 8.32% | 100.90% |